Augmented Bionics is developing a non-invasive neurostimulation technology suitable for many clinical applications. The company has raised its seed investment and is on its path to commercialise its first product in the hearing space. The product aims to bridge the gap between hearing aids and cochlear implants in the severe hearing loss segment. The current market penetration of hearing implants is <5%, so the company has a huge opportunity.